Related references
Note: Only part of the references are listed.Assessing options for treating haemophilia with inhibitors
A. Farrugia et al.
HAEMOPHILIA (2015)
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment
S. R. Earnshaw et al.
HAEMOPHILIA (2015)
Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain
R. Villarrubia et al.
HAEMOPHILIA (2015)
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy
F. Abbonizio et al.
HAEMOPHILIA (2014)
ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective
J. Oldenburg et al.
HAEMOPHILIA (2014)
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)
Peter W. Collins et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution?
G. Di Minno et al.
HAEMOPHILIA (2013)
Guidelines for the management of hemophilia
A. Srivastava et al.
HAEMOPHILIA (2013)
The principal results of the International Immune Tolerance Study: a randomized dose comparison
Charles R. M. Hay et al.
BLOOD (2012)
Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
Cindy Leissinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches
Antonio Coppola et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors
A. Coppola et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
International workshop on immune tolerance induction: consensus recommendations
D. M. Dimichele et al.
HAEMOPHILIA (2007)
Assessing the costs for clinical care of patients with high-responding factor VIII and IX inhibitors
M. Ullman et al.
HAEMOPHILIA (2006)
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors
J Astermark et al.
HAEMOPHILIA (2006)
Health economics of treating haemophilia A with inhibitors
C Knight
HAEMOPHILIA (2005)
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany
G Auerswald et al.
HAEMOPHILIA (2004)
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
A Gringeri et al.
BLOOD (2003)
The epidemiology of inhibitors in haemophilia A: a systematic review
J Wight et al.
HAEMOPHILIA (2003)
Immune tolerance treatment in haemophilia patients with inhibitors:: the Spanish Registry
S Haya et al.
HAEMOPHILIA (2001)
Share Paper
